| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/22/2003 | EP1276501A2 Method for treatment of tumors using photodynamic therapy |
| 01/22/2003 | EP1276500A1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 01/22/2003 | EP1276499A2 Equine protozoal myeloencephalitis vaccine |
| 01/22/2003 | EP1276496A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 01/22/2003 | EP0653067B1 Method and kit for pyridinium crosslink assay |
| 01/22/2003 | EP0610436B1 Hepatitis-c virus testing |
| 01/21/2003 | WO2004009834A2 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | US6509453 Use of oil bodies and their associated proteins as affinity matrices for the separation and purification of target molecules from samples |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509314 Methods of preventing or reducing scarring with decorin or biglycan |
| 01/21/2003 | US6509173 Related members of a broad class of polypeptide mediators, which includes the interferons, interleukins and growth factors, collectively called cytokines |
| 01/21/2003 | US6509170 Polynucleotides encoding human tumor necrosis factor delta |
| 01/21/2003 | US6509162 Methods for selectively modulating survivin apoptosis pathways |
| 01/21/2003 | US6509152 Immunosuppressant target proteins |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509019 Immunologically active proteins from Borrelia burgdorferi |
| 01/21/2003 | US6509018 Expressed peptides, in particular a strain designated YBF30; including V3 loop region and corresponding nucleotide sequences |
| 01/21/2003 | US6509017 Vaccines containing nucleic acid fragments encoding antigenic proteins that increase resistance to infection; isolated, purified polypeptide having amino acid sequence 1-598 of seq id no: 6 or 1-600 of seq id no: 8 |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | CA2453344A1 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | CA2204253C Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 01/21/2003 | CA2096529C Recombinant avirulent salmonella antifertility vaccines |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/16/2003 | WO2003005636A1 Secure header information for multi-content e-mail |
| 01/16/2003 | WO2003005036A2 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | WO2003005033A2 Carcinoma-related peptides |
| 01/16/2003 | WO2003004992A2 Mammalian sweet and amino acid heterodimeric taste receptors |
| 01/16/2003 | WO2003004694A1 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 01/16/2003 | WO2003004651A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | WO2003004648A1 Anti_human ovarian cancer -anti_cd3 bispecific antibody |
| 01/16/2003 | WO2003004636A2 Expression vectors encoding bacteriophage signal peptides |
| 01/16/2003 | WO2003004627A2 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004607A2 Aggrecanase molecules |
| 01/16/2003 | WO2003004533A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 01/16/2003 | WO2003004532A2 Q9ul33/q9nzz4 and q9h5p3 splice variants |
| 01/16/2003 | WO2003004520A2 Mycobacterial antigens expressed during latency |
| 01/16/2003 | WO2003004056A1 Method for treating multiple myeloma |
| 01/16/2003 | WO2003004050A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | WO2003004049A2 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 01/16/2003 | WO2003003986A2 Parathyroid hormone antibodies and related methods |
| 01/16/2003 | WO2003003906A2 Diagnostic and screening methods for bladder cancer |
| 01/16/2003 | WO2003003904A2 Coactivators in the diagnosis and treatment of breast cancer |
| 01/16/2003 | WO2002094194A3 Compositions and methods for inhibiting metastasis |
| 01/16/2003 | WO2002077023A3 A new essential downstream component of the wingless signalling pathway |
| 01/16/2003 | WO2002059148A8 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/16/2003 | WO2002046769A3 A monoclonal antibody-based diagnostic assay for gamma fibrinogen |
| 01/16/2003 | WO2002043661A3 Recombinant anti-cd30 antibodies and uses thereof |
| 01/16/2003 | WO2002038177A3 Adjuvant combination formulations |
| 01/16/2003 | WO2002037119A3 Method of diagnosing a transmissible spongiform encephalopathy |
| 01/16/2003 | WO2002032286A3 Protein-protein interactions in neurodegenerative diseases |
| 01/16/2003 | WO2002031144A3 Identification of cytotoxic activity from the ink of aplysia punctata |
| 01/16/2003 | WO2002027017A3 Method for quantifying phosphokinase activity on proteins |
| 01/16/2003 | WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 01/16/2003 | WO2002021141A3 Methods and compositions for diseases associated with amyloidosis |
| 01/16/2003 | WO2002020813A3 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 01/16/2003 | WO2002016595A3 Kidney-specific protein |
| 01/16/2003 | WO2002016587A3 Microtubule-associated proteins and tubulins |
| 01/16/2003 | WO2002016581A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/16/2003 | WO2002014352A3 Therapeutic compounds for ovarian cancer |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2002004021A9 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/16/2003 | WO2002002783A3 Expression vectors |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001092490A3 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 01/16/2003 | WO2001090192A3 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001070174A8 Vegf-modulated genes and methods employing them |
| 01/16/2003 | WO2001068880A9 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | WO2001068123A9 Monocyte chemoattractant activity of galectin-3 |
| 01/16/2003 | WO2001064944A9 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013856 High affinity humanized anti-TAG-72 monoclonalantibodies |
| 01/16/2003 | US20030013855 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/16/2003 | US20030013854 Tumor-associated glycoprotein (tag-72) murine antibody used to detect cancer |
| 01/16/2003 | US20030013850 Antiinflammatory agents |
| 01/16/2003 | US20030013844 Multimerization of HIV-1 Vif protein as a therapeutic target |
| 01/16/2003 | US20030013643 Prevention and treatment of streptococcal and staphylococcal infection |
| 01/16/2003 | US20030013194 Prevention of membrane formation; obtain cell tissue, incubate with inhibitory collagen, monitor membrane formation |
| 01/16/2003 | US20030013191 Transgenic cells for use in human therapeutics and diagnostics |
| 01/16/2003 | US20030013183 Genetic engineering; medical diagnosis; prevent immunology response |
| 01/16/2003 | US20030013181 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 01/16/2003 | US20030013157 Culturing cells which generate preferential immunoglobulins; obtain cell, transform cell, recover cell expressing preferential immunoglobulin, isolate immunoglobulin |
| 01/16/2003 | US20030013149 Quantitative analysis |
| 01/16/2003 | US20030013131 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/16/2003 | US20030013119 Gustducin materials and methods |
| 01/16/2003 | US20030013108 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/16/2003 | US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/16/2003 | US20030013081 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 01/16/2003 | US20030013077 Binding to monoclonal antibodies; detection of Kaposi's sarcoma |